HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Seeber Selected Research

Etoposide (VP 16)

2/2007Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
1/2003Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of peripheral blood stem cells in cancer patients.
6/2000Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the upper-thoracic and midthoracic esophagus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Seeber Research Topics

Disease

19Neoplasms (Cancer)
05/2006 - 01/2000
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2007 - 02/2000
6Breast Neoplasms (Breast Cancer)
01/2005 - 06/2001
6Ovarian Neoplasms (Ovarian Cancer)
03/2003 - 01/2000
4Carcinoma (Carcinomatosis)
05/2006 - 01/2000
4Sarcoma (Soft Tissue Sarcoma)
04/2004 - 02/2000
4Testicular Neoplasms (Testicular Cancer)
06/2003 - 02/2000
4Residual Neoplasm
05/2002 - 10/2000
3Body Weight (Weight, Body)
03/2005 - 01/2001
2Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2009 - 02/2007
2Lymphoma (Lymphomas)
02/2007 - 01/2003
2Multiple Myeloma
03/2005 - 01/2005
2Disease Progression
01/2005 - 03/2001
2Colorectal Neoplasms (Colorectal Cancer)
09/2003 - 03/2001
2Neoplasm Micrometastasis
05/2002 - 06/2001
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2001 - 10/2000
2Lung Neoplasms (Lung Cancer)
04/2000 - 02/2000
1Inflammation (Inflammations)
09/2013
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
09/2013
1Cardiotoxicity
03/2009
1Hodgkin Disease (Hodgkin's Disease)
02/2007
1Mesothelioma
05/2006
1Diarrhea
05/2006
1Neoplasm Metastasis (Metastasis)
05/2006
1Neutropenia
05/2006
1Peritoneal Neoplasms
05/2006
1Stomatitis
05/2006
1Exanthema (Rash)
03/2006
1Fever (Fevers)
02/2006
1Hemolytic-Uremic Syndrome
02/2005
1Infections
01/2005
1Mullerian aplasia
01/2005
1Polyneuropathies (Polyneuropathy)
01/2005
1Hemangiosarcoma (Angiosarcoma)
04/2004
1Leiomyosarcoma
04/2004
1Osteonecrosis (Kienbock's Disease)
03/2003
1Necrosis
03/2003

Drug/Important Bio-Agent (IBA)

6Cisplatin (Platino)FDA LinkGeneric
10/2004 - 02/2000
5Sorafenib (BAY 43-9006)FDA Link
05/2006 - 12/2002
3AnthracyclinesIBA
03/2009 - 01/2003
3Etoposide (VP 16)FDA LinkGeneric
02/2007 - 06/2000
3IfosfamideFDA LinkGeneric
02/2007 - 02/2000
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2007 - 01/2003
3Cytarabine (Cytosar-U)FDA LinkGeneric
02/2007 - 10/2000
3Pharmaceutical PreparationsIBA
05/2006 - 04/2000
3Vincristine (Oncovin)FDA LinkGeneric
01/2005 - 01/2001
3Paclitaxel (Taxol)FDA LinkGeneric
10/2004 - 02/2000
3raf KinasesIBA
12/2003 - 12/2002
3treosulfanIBA
03/2003 - 01/2000
3Keratins (Keratin)IBA
05/2002 - 06/2001
2Dexamethasone (Maxidex)FDA LinkGeneric
02/2007 - 01/2005
2Doxorubicin (Adriamycin)FDA LinkGeneric
05/2006 - 12/2003
2GemcitabineFDA Link
02/2005 - 04/2004
2Antineoplastic Agents (Antineoplastics)IBA
02/2005 - 02/2000
2Epirubicin (Ellence)FDA LinkGeneric
01/2005 - 10/2004
2Capecitabine (Xeloda)FDA Link
01/2005 - 09/2003
2Proteins (Proteins, Gene)FDA Link
01/2005 - 07/2000
2CamptothecinIBA
08/2004 - 03/2001
2Irinotecan (Camptosar)FDA LinkGeneric
09/2003 - 03/2001
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2003 - 10/2000
2CK 17IBA
05/2002 - 06/2001
2AntigensIBA
05/2002 - 06/2001
2Tumor Biomarkers (Tumor Markers)IBA
05/2002 - 09/2001
2N 30IBA
05/2002 - 06/2001
2Complementary DNA (cDNA)IBA
07/2001 - 07/2000
2Alkylating AgentsIBA
04/2000 - 01/2000
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2013
1CytokinesIBA
09/2013
1Melphalan (Alkeran)FDA LinkGeneric
02/2007
1tyrosine receptor (receptor, tyrosine)IBA
05/2006
1Phosphotransferases (Kinase)IBA
05/2006
1Serine (L-Serine)FDA Link
05/2006
1Threonine (L-Threonine)FDA Link
05/2006
1Oxygen (Dioxygen)IBA
12/2005
1SolutionsIBA
12/2005
1Filgrastim (Neupogen)FDA Link
03/2005
1LenograstimIBA
03/2005
1Mitomycin (Mitomycin-C)FDA LinkGeneric
02/2005
1Anti-Mullerian HormoneIBA
01/2005
1Thalidomide (Thalomid)FDA Link
01/2005
1Taxoids (Taxanes)IBA
01/2005
1taxaneIBA
01/2005
1Vinorelbine (Navelbine)FDA LinkGeneric
01/2005
120- O- (Nalpha- (4- (3- O- methylfucopyranosyloxy)phenylaminothiocarbonyl)histidylvalyl)camptothecinIBA
08/2004
1GlycoconjugatesIBA
08/2004
1NucleosidesIBA
04/2004
1Cytostatic AgentsIBA
04/2004
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2003
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2003

Therapy/Procedure

21Drug Therapy (Chemotherapy)
03/2009 - 06/2000
7Therapeutics
01/2007 - 10/2000
6Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
02/2007 - 11/2000
4Transplantation
06/2003 - 10/2000
3Induction Chemotherapy
10/2004 - 06/2000
2Combination Drug Therapy (Combination Chemotherapy)
03/2009 - 05/2006
2Stem Cell Transplantation
02/2007 - 10/2004
2Radiotherapy
03/2002 - 06/2000
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
04/2001 - 10/2000
1Salvage Therapy
02/2007
1Adjuvant Chemotherapy
10/2004